The decision should be made with a qualified clinician
The TRIUMPH-2 and TRIUMPH-3 studies met their primary endpoints, with results supporting retatrutide's potential use in people with obesity and associated cardiometabolic complications
This ensures consistent access to prescriptions, especially for skin, hair, and weight loss programs that require continuity
Mounjaro is approved for managing type 2 diabetes, while Zepbound focuses on chronic weight management for adults with obesity or those overweight with a related condition like high blood pressure, high cholesterol, or type 2 diabetes
Available from: Tsai TH, Lee CH, Cheng CI, Fang YN, Chung SY, Chen SM, et al
Compounded versions sometimes use semaglutide salts, which have not been proven safe or effective